Shane M. Cooke's holdings in Alkermes have seen interesting fluctuations over the years. In 2020, his vested stock value was around $2.55 million, at a time when the company was achieving significant pipeline development milestones. By 2023, Cooke's holdings increased...

Shane M. Cooke's holdings in Alkermes have seen interesting fluctuations over the years. In 2020, his vested stock value was around $2.55 million, at a time when the company was achieving significant pipeline development milestones. By 2023, Cooke's holdings increased dramatically, with vesting performance-vesting restricted stock units valued at approximately $6.06 million as they met certain financial targets. The value of his holdings represents a substantial portion of his wealth and indicates his strong belief in Alkermes' growth trajectory. His strategic management and insight have been crucial in navigating the complex biopharmaceutical market.